ArticleFrontiers in pharmacology2025

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database.

Fang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.